Myocarditis Following Immunization With mRNA COVID-19 Vaccines in Members of the US Military.

ABSTRACT:

Importance

Myocarditis has been reported with COVID-19 but is not clearly recognized as a possible adverse event following COVID-19 vaccination.

Objective

To describe myocarditis presenting after COVID-19 vaccination within the Military Health System.

Design, setting, and participants

This retrospective case series studied patients within the US Military Health System who experienced myocarditis after COVID-19 vaccination between January and April 2021. Patients who sought care for chest pain following COVID-19 vaccination and were subsequently diagnosed with clinical myocarditis were included.

Exposure

Receipt of a messenger RNA (mRNA) COVID-19 vaccine between January 1 and April 30, 2021.

Main outcomes and measures

Clinical diagnosis of myocarditis aft

SUBMITTER: Montgomery J 

PROVIDER: S-EPMC8243257 | biostudies-literature | 2021 Oct

REPOSITORIES: biostudies-literature